Literature DB >> 8090255

Smoking and Alzheimer's disease: a review of the epidemiological evidence.

P N Lee1.   

Abstract

Overall evidence from 19 case-control studies of Alzheimer's disease (AD) and smoking shows a highly significant (p < 0.001) negative association [ever/never smokers, relative risk (RR) 0.64, 95% confidence interval (CI) 0.54-0.76]. Some studies have apparent design faults but the association is clearly evident in those which do not (RR 0.60, 95% CI 0.46-0.78). A report of a positive relationship from a prospective study can be dismissed due to unreliability of AD diagnosis on death certificates, and other study weaknesses. Although more data are needed on dose response and to rule out possible confounding, the negative association is consistent with other data suggesting nicotine protects against AD.

Entities:  

Mesh:

Year:  1994        PMID: 8090255     DOI: 10.1159/000110372

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  36 in total

1.  Smoking and dementia in male British doctors: prospective study.

Authors:  R Doll; R Peto; J Boreham; I Sutherland
Journal:  BMJ       Date:  2000-04-22

2.  Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.

Authors:  Janine K Cataldo; Judith J Prochaska; Stanton A Glantz
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Gender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjects.

Authors:  Young-Hoon Sung; Deborah A Yurgelun-Todd; Douglas G Kondo; Xian-Feng Shi; Kelly J Lundberg; Tracy L Hellem; Rebekah S Huber; Erin C McGlade; Eun-Kee Jeong; Perry F Renshaw
Journal:  Am J Drug Alcohol Abuse       Date:  2015-04-14       Impact factor: 3.829

4.  Neuroprotection in Alzheimer's disease - new strategies for treatment.

Authors:  A Nordberg
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

5.  Secondhand smoke, vascular disease, and dementia incidence: findings from the cardiovascular health cognition study.

Authors:  Deborah E Barnes; Thaddeus J Haight; Kala M Mehta; Michelle C Carlson; Lewis H Kuller; Ira B Tager
Journal:  Am J Epidemiol       Date:  2010-01-05       Impact factor: 4.897

Review 6.  Elevation of intracellular calcium levels in neurons by nicotinic acetylcholine receptors.

Authors:  M M Rathouz; S Vijayaraghavan; D K Berg
Journal:  Mol Neurobiol       Date:  1996-04       Impact factor: 5.590

Review 7.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

8.  Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease.

Authors:  Ines Moreno-Gonzalez; Lisbell D Estrada; Elisabeth Sanchez-Mejias; Claudio Soto
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 9.  Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

Authors:  P A Newhouse; A Potter; E D Levin
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

10.  Effects of nicotine and mecamylamine on cognition in rhesus monkeys.

Authors:  Simon N Katner; Sophia A Davis; Amber J Kirsten; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.